Baugh & Associates’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.35M Sell
42,743
-2,214
-5% -$381K 3.83% 9
2025
Q1
$9.06M Sell
44,957
-219
-0.5% -$44.1K 4.59% 5
2024
Q4
$7.77M Buy
45,176
+816
+2% +$140K 4.03% 9
2024
Q3
$8.53M Buy
44,360
+390
+0.9% +$75K 4.39% 6
2024
Q2
$7.9M Sell
43,970
-2,236
-5% -$402K 4.1% 6
2024
Q1
$8.41M Sell
46,206
-33
-0.1% -$6.01K 4.48% 6
2023
Q4
$7.17M Sell
46,239
-636
-1% -$98.6K 4.12% 6
2023
Q3
$6.99M Sell
46,875
-136
-0.3% -$20.3K 4.37% 5
2023
Q2
$6.33M Buy
47,011
+685
+1% +$92.3K 3.81% 6
2023
Q1
$7.51M Sell
46,326
-966
-2% -$157K 4.8% 5
2022
Q4
$7.64M Sell
47,292
-12
-0% -$1.94K 4.95% 4
2022
Q3
$6.35M Sell
47,304
-17
-0% -$2.28K 4.49% 6
2022
Q2
$7.25M Sell
47,321
-525
-1% -$80.4K 4.88% 3
2022
Q1
$7.76M Sell
47,846
-230
-0.5% -$37.3K 4.56% 3
2021
Q4
$6.51M Buy
48,076
+369
+0.8% +$50K 3.6% 10
2021
Q3
$5.15M Sell
47,707
-4
-0% -$431 3.15% 11
2021
Q2
$5.37M Sell
47,711
-576
-1% -$64.9K 3.33% 10
2021
Q1
$5.23M Buy
48,287
+159
+0.3% +$17.2K 3.45% 10
2020
Q4
$5.16M Buy
48,128
+538
+1% +$57.6K 3.68% 7
2020
Q3
$4.17M Sell
47,590
-825
-2% -$72.3K 3.27% 9
2020
Q2
$4.75M Buy
48,415
+976
+2% +$95.8K 3.79% 8
2020
Q1
$3.61M Sell
47,439
-504
-1% -$38.4K 3.49% 8
2019
Q4
$4.25M Sell
47,943
-450
-0.9% -$39.8K 3.1% 11
2019
Q3
$3.66M Buy
48,393
+255
+0.5% +$19.3K 2.84% 17
2019
Q2
$3.5M Buy
48,138
+6,858
+17% +$499K 2.77% 19
2019
Q1
$3.33M Sell
41,280
-238
-0.6% -$19.2K 2.67% 21
2018
Q4
$3.83M Sell
41,518
-60
-0.1% -$5.53K 3.3% 7
2018
Q3
$3.93M Buy
41,578
+1,264
+3% +$120K 3.14% 10
2018
Q2
$3.74M Sell
40,314
-1,631
-4% -$151K 3.26% 6
2018
Q1
$3.97M Sell
41,945
-355
-0.8% -$33.6K 3.2% 8
2017
Q4
$4.09M Buy
+42,300
New +$4.09M 3.45% 7